Diagnosis significance of Morphous and gene characteristic between MDS and Hemolytic Anemia

Hui-yuan KANG,Mian-yang LI,Yu-ling PAN,Gai-xia LIU,Xiao-qian FENG,Cheng-bin WANG
DOI: https://doi.org/10.3969/j.issn.1672-9455.2014.23.001
2014-01-01
Abstract:Objective To analyze the clinical significance of morphous and genetic tests difference between my‐elodysplastic syndrome (MDS) and hemolytic anemia (HA) patients. Methods Analyse the differences of clinical da‐ta, morphous(bone marrow blast and dyshaematopoiesis) and genetic status(karyotype and gene) in 56 MDS patients and 44 HA patients. Results Dyshaematopoiesis(P=0. 001), bone marrow blast counts(P=0. 002), abnormal Kary‐otype(P=0. 000) and abnormal genes(P=0. 000) had significant differences in MDS patients and HA patients. NO significant differences between MDS patients and HA patients were performed in clinical data(P>0. 05). Conclusion Combining morphous and genetic tests was more useful for making difference MDS patients with HA patients.
What problem does this paper attempt to address?